FUSO PHARMACEUTICAL INDUSTRIES,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,211 JPY | -0.14% |
|
+0.55% | +16.92% |
| Sales 2014 * | 49.43B 312M 26.03B | Sales 2015 * | 47.73B 301M 25.13B | Capitalization | 18.71B 118M 9.85B |
|---|---|---|---|---|---|
| Net income 2014 * | - | Net income 2015 * | - | EV / Sales 2014 * | 0.38 x |
| Net cash position 2014 * | - 0 0 | Net cash position 2015 * | - 0 0 | EV / Sales 2015 * | 0.39 x |
| P/E ratio 2014 * |
10.1
x | P/E ratio 2015 * |
36.2
x | Employees | 1,370 |
| Yield 2014 * |
-
| Yield 2015 * |
-
| Free-Float | 71.02% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.14% | ||
| 1 week | +0.55% | ||
| Current month | +0.45% | ||
| 1 month | -5.67% | ||
| 3 months | -0.50% | ||
| 6 months | +13.97% | ||
| Current year | +16.92% |
1 week
2 199.00
2 242.00
1 month
2 126.002 324.00
Current year
1 888.002 363.00
1 year
1 841.002 363.00
3 years
1 841.002 710.00
5 years
1 320.003 090.00
10 years
1 320.003 390.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mikio Toda
PSD | President | 81 | 01/66/01 |
Masanori Ito
CTO | Chief Tech/Sci/R&D Officer | 73 | 01/74/01 |
| Chief Administrative Officer | 76 | 01/72/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mikio Toda
PSD | President | 81 | 01/66/01 |
| Chief Administrative Officer | 76 | 01/72/01 | |
Yukinobu Matsui
PRN | Corporate Officer/Principal | 77 | 01/69/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 15 M€ | +7.34% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 20,721 M€ | +13.52% | - | |
| 0.00% | 66,066 M€ | +14.68% | - | |
| 0.00% | 144,586 M€ | +14.49% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 2,211 | -0.14% | 13,000 |
| 25/24/25 | 2,214 | -0.76% | 8,400 |
| 24/24/24 | 2,231 | +0.90% | 12,700 |
| 23/24/23 | 2,211 | +0.14% | 3,700 |
| 22/24/22 | 2,208 | +0.41% | 11,500 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
Sector
Pharmaceuticals
Calendar
10/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +16.92% | 119M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4538 Stock
